Genetic determinants of HIV-1 infection and progression to AIDS: Immune response genes

Tissue Antigens

Volumn 74, Issue 5, 2009, Pages 373-385

  Kaur, G ^a   Mehra, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acquired immune deficiency syndrome; Cytokines; Genetic susceptibility; Human immunodeficiency virus; Major histocompatibility complex

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B35 ANTIGEN; HLA B57 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDINAVIR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; NEVIRAPINE; SAQUINAVIR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DOWN REGULATION; DRUG SENSITIVITY; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA TYPING; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; GENES, MHC CLASS II; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; POLYMORPHISM, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70350060177     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01337.x     Document Type: Review

References (50)

1. Kaur G, Mehra N. Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens 2009 : 73 : 289 301.
2. Mahungu TW, Johnson MA, Owen A, Back DJ. The impact of pharmacogenetics on HIV therapy. Int J STD AIDS 2009 : 20 : 145 151.
3. Fellay J, Shianna KV, Ge D et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007 : 317 : 944 947.
4. Catano G, Kulkarni H, He W et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One 2008 : 3 : e3636.
5. Colombo S, Rauch A, Rotger M et al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. J Infect Dis 2008 : 198 : 864 867.
6. Chessman D, Kostenko L, Lethborg T et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 2008 : 28 : 822 832.
7. Carrington M, Nelson GW, Martin MP et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999 : 283 : 1748 1752.
8. Dalmau J, Puertas MC, Azuara M et al. Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection. Clin Infect Dis 2009 : 48 : 229 238.
9. Tang J, Shao W, Yoo YJ et al. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol 2008 : 181 : 2626 2635.
10. Goulder PJ, Brander C, Tang Y et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001 : 412 : 334 338.
11. Schneidewind A, Tang Y, Brockman MA et al. Maternal transmission of HIV escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J Virol 2009 : JVI.00730-09v1 Jun 10. [Epub ahead of print]
12. Rousseau CM, Lockhart DW, Listgarten J et al. Rare HLA drive additional HIV evolution compared to more frequent alleles. AIDS Res Hum Retroviruses 2009 : 25 : 297 303.
13. Kawashima Y, Pfafferott K, Frater J et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009 : 458 : 641 645.
14. Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002 : 359 : 727 732.
15. Rauch A, Nolan D, Thurnheer C et al. Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antivir Ther 2008 : 13 : 1019 1028.
16. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 2007 : 149 : 1 8.
17. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002 : 31 : 429 434.
18. Jennes W, Verheyden S, Demanet C et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006 : 177 : 6588 6592.
19. Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, Roger M. Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 2006 : 193 : 298 301.
20. Habeshaw JA, Wilson SE, Hounsell EF, Oxford JS. How HIV-1 lentivirus causes immune deficiency disease. Med Hypotheses 1999 : 52 : 59 67.
21. Cadogan M, Austen B, Heeney JL, Dalgleish AG. HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120. AIDS Res Hum Retroviruses 2008 : 24 : 845 855.
22. de Parseval A, Bobardt MD, Chatterji A et al. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J Biol Chem 2005 : 280 : 39493 39504.
23. Masemola A, Mashishi T, Khoury G et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 2004 : 78 : 3233 3243.
24. Altfeld M, Kalife ET, Qi Y et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006 : 3 : e403.
25. Kiepiela P, Leslie AJ, Honeyborne I et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004 : 432 : 769 775.
26. Goulder PJ, Phillips RE, Colbert RA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997 : 3 : 212 217.
27. Migueles SA, Sabbaghian MS, Shupert WL et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000 : 97 : 2709 2714.
28. Gao X, Nelson GW, Karacki P et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001 : 344 : 1668 1675.
29. Gao X, Bashirova A, Iversen AK et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005 : 11 : 1290 1292.
30. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005 : 191 (Suppl 1 S68 77.
31. Cornelissen M, Hoogland FM, Back NK et al. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands. AIDS 2009 : 23 : 1495 1500.
32. Gillespie GM, Kaul R, Dong T et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002 : 16 : 961 972.
33. Miura T, Brockman MA, Schneidewind A et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 2009 : 83 : 2743 2755.
34. Yu XG, Lichterfeld M, Chetty S et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol 2007 : 81 : 1619 1631.
35. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004 : 36 : 565 574.
36. Malhotra U, Holte S, Dutta S et al. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J Clin Invest 2001 : 107 : 505 517.
37. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci U S A 1995 : 92 : 12374 12378.
38. MacDonald KS, Fowke KR, Kimani J et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000 : 181 : 1581 1589.
39. Liu C, Carrington M, Kaslow RA et al. Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2003 : 187 : 1404 1410.
40. Flores-Villanueva PO, Hendel H, Caillat-Zucman S et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol 2003 : 170 : 1925 1929.
41. Singh P, Kaur G, Sharma G, Mehra NK. Immunogenetic basis of HIV-1 infection, transmission and disease progression. Vaccine 2008 : 26 : 2966 2980.
42. Stephens HA. HIV-1 diversity versus HLA class I polymorphism. Trends Immunol 2005 : 26 : 41 7.
43. Kaur G, Kumar N, Szilagyi A et al. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G. Hum Immunol 2008 : 69 : 580 587.
44. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK. Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens 2007 : 69 : 113 120.
45. Hoffmann SC, Stanley EM, Cox ED et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002 : 2 : 560 567.
46. Hogan CM, Hammer SM. Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med 2001 : 134 : 978 996.
47. Weissman D, Poli G, Fauci AS. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 1994 : 10 : 1199 1206.
48. Price P, Morahan G, Huang D et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002 : 16 : 2043 2047.
49. Loeuillet C, Deutsch S, Ciuffi A et al. In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol 2008 : 6 : e32.
50. Shrestha S, Aissani B, Song W, Wilson CM, Kaslow RA, Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 2009 : 23 : 673 677.